(UEF5) UBS MSCI Emerging Markets - Ratings and Ratios
waste, water, soil, renewable, conservation
Dividends
| Dividend Yield | 2.19% |
| Yield on Cost 5y | 2.82% |
| Yield CAGR 5y | 7.68% |
| Payout Consistency | 93.5% |
| Payout Ratio | - |
| Risk via 5d forecast | |
|---|---|
| Volatility | 15.4% |
| Value at Risk 5%th | 23.9% |
| Relative Tail Risk | -5.80% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.62 |
| Alpha | 12.80 |
| CAGR/Max DD | 0.56 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.332 |
| Beta | 0.198 |
| Beta Downside | 0.492 |
| Drawdowns 3y | |
|---|---|
| Max DD | 20.41% |
| Mean DD | 4.75% |
| Median DD | 4.21% |
Description: UEF5 UBS MSCI Emerging Markets November 13, 2025
UBS MSCI Emerging Markets Socially Responsible UCITS A-dis (XETRA: UEF5) is a Germany-domiciled ETF that tracks the Morningstar EM TME NR USD index, providing exposure to large- and mid-cap equities across emerging markets while screening out companies that fall short on environmental, social, and governance (ESG) criteria.
Key metrics as of Q3 2024: the fund carries an expense ratio of 0.25 % and holds roughly €1.2 billion in assets under management. Its top ten holdings are heavily weighted toward technology (≈ 30 % of the portfolio) and consumer discretionary (≈ 20 %), with Taiwan Semiconductor Manufacturing and Tencent among the largest constituents. The underlying index’s ESG-screened methodology has historically delivered a modest ESG-score premium of about 0.5 % annualized excess return versus the broader MSCI Emerging Markets index, while still tracking the region’s growth drivers such as China’s manufacturing rebound and higher commodity demand from India and Brazil.
If you want a data-rich, risk-adjusted view of how UEF5’s ESG tilt interacts with emerging-market fundamentals, a deeper look on the ValueRay platform could be worthwhile.
What is the price of UEF5 shares?
Over the past week, the price has changed by +0.60%, over one month by +1.73%, over three months by +6.82% and over the past year by +19.32%.
Is UEF5 a buy, sell or hold?
What are the forecasts/targets for the UEF5 price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 16.6 | 7.8% |
UEF5 Fundamental Data Overview December 29, 2025
Market Cap EUR = 2.16b (2.16b EUR * 1.0 EUR.EUR)
Beta = 0.0
Revenue TTM = 0.0 EUR
EBIT TTM = 0.0 EUR
EBITDA TTM = 0.0 EUR
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 2.16b EUR (2.16b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 2.16b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 2.16b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 25.0% (EU avg default 25%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 25.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 6.74% (E(2.16b)/V(2.16b) * Re(6.74%) + (debt-free company))
Discount Rate = 6.74% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Fair Price DCF = unknown (Cash Flow 0.0)